日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial

评估循环microRNA在预测乳腺癌长期生存结果中的作用:一项前瞻性多中心临床试验

Davey, Matthew G; McGuire, Andrew; Casey, Maire Caitlin; Waldron, Ronan M; Paganga, Maxwell; Holian, Emma; Newell, John; Heneghan, Helen M; McDermott, Ailbhe M; Keane, Maccon M; Lowery, Aoife J; Miller, Nicola; Kerin, Michael J

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer

循环microRNA可以预测接受原发性乳腺癌治疗患者的化疗毒性

Davey, Matthew G; Abbas, Ray; Kerin, Eoin P; Casey, Maire Caitlin; McGuire, Andrew; Waldron, Ronan M; Heneghan, Helen M; Newell, John; McDermott, Ailbhe M; Keane, Maccon M; Lowery, Aoife J; Miller, Nicola; Kerin, Michael J

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial

评估循环microRNA在乳腺癌新辅助化疗治疗决策中的作用:一项前瞻性多中心临床试验

Davey, Matthew G; Casey, Maire Caitlin; McGuire, Andrew; Waldron, Ronan M; Paganga, Maxwell; Holian, Emma; Newell, John; Heneghan, Helen M; McDermott, Ailbhe M; Keane, Maccon M; Lowery, Aoife J; Miller, Nicola; Kerin, Michael J

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©

一种能够预测OncotypeDX复发评分©的新型替代列线图

Davey, Matthew G; Jalali, Amirhossein; Ryan, Éanna J; McLaughlin, Ray P; Sweeney, Karl J; Barry, Michael K; Malone, Carmel M; Keane, Maccon M; Lowery, Aoife J; Miller, Nicola; Kerin, Michael J

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort study

新辅助治疗的临床病理反应和病理完全缓解作为人表皮生长因子受体-2富集型乳腺癌生存的生物标志物——一项回顾性队列研究

Davey, Matthew G; Kerin, Eoin; O'Flaherty, C; Maher, Elizabeth; Richard, Vinitha; McAnena, Peter; McLaughlin, Ray P; Sweeney, Karl J; Barry, Michael K; Malone, Carmel M; Wyns, William; Soliman, Osama; Miller, Nicola; Keane, Maccon M; Lowery, Aoife J; Kerin, Michael J

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

随机TAILORx试验中激素受体阳性、HER2阴性、淋巴结阴性乳腺癌患者的种族、民族和临床结果

Albain, Kathy S; Gray, Robert J; Makower, Della F; Faghih, Amir; Hayes, Daniel F; Geyer, Charles E; Dees, Elizabeth C; Goetz, Matthew P; Olson, John A; Lively, Tracy; Badve, Sunil S; Saphner, Thomas J; Wagner, Lynne I; Whelan, Timothy J; Ellis, Matthew J; Wood, William C; Keane, Maccon M; Gomez, Henry L; Reddy, Pavan S; Goggins, Timothy F; Mayer, Ingrid A; Brufsky, Adam M; Toppmeyer, Deborah L; Kaklamani, Virginia G; Berenberg, Jeffrey L; Abrams, Jeffrey; Sledge, George W; Sparano, Joseph A

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"

Copanlisib(一种磷脂酰肌醇-3激酶 (PI3K) 抑制剂)联合曲妥珠单抗治疗晚期预处理 HER2 阳性乳腺癌的 Ib 期试验“PantHER”

Keegan, Niamh M; Furney, Simon J; Walshe, Janice M; Gullo, Giuseppe; Kennedy, M John; Smith, Diarmuid; McCaffrey, John; Kelly, Catherine M; Egan, Keith; Kerr, Jennifer; Given, Mark; O'Donovan, Peter; Hernando, Andres; Teiserskiene, Ausra; Parker, Imelda; Kay, Elaine; Farrelly, Angela; Carr, Aoife; Calzaferri, Giulio; McDermott, Ray; Keane, Maccon M; Grogan, Liam; Breathnach, Oscar; Morris, Patrick G; Toomey, Sinead; Hennessy, Bryan T

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

早期乳腺癌患者(21基因复发评分26至100)接受辅助化疗联合内分泌治疗的临床结果:TAILORx随机临床试验的二次分析

Sparano, Joseph A; Gray, Robert J; Makower, Della F; Albain, Kathy S; Saphner, Thomas J; Badve, Sunil S; Wagner, Lynne I; Kaklamani, Virginia G; Keane, Maccon M; Gomez, Henry L; Reddy, Pavan S; Goggins, Timothy F; Mayer, Ingrid A; Toppmeyer, Deborah L; Brufsky, Adam M; Goetz, Matthew P; Berenberg, Jeffrey L; Mahalcioiu, Catalin; Desbiens, Christine; Hayes, Daniel F; Dees, Elizabeth C; Geyer, Charles E Jr; Olson, John A Jr; Wood, William C; Lively, Tracy; Paik, Soonmyung; Ellis, Matthew J; Abrams, Jeffrey; Sledge, George W Jr

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

临床和基因组风险指导乳腺癌辅助治疗的应用

Sparano, Joseph A; Gray, Robert J; Ravdin, Peter M; Makower, Della F; Pritchard, Kathleen I; Albain, Kathy S; Hayes, Daniel F; Geyer, Charles E Jr; Dees, Elizabeth C; Goetz, Matthew P; Olson, John A Jr; Lively, Tracy; Badve, Sunil S; Saphner, Thomas J; Wagner, Lynne I; Whelan, Timothy J; Ellis, Matthew J; Paik, Soonmyung; Wood, William C; Keane, Maccon M; Gomez Moreno, Henry L; Reddy, Pavan S; Goggins, Timothy F; Mayer, Ingrid A; Brufsky, Adam M; Toppmeyer, Deborah L; Kaklamani, Virginia G; Berenberg, Jeffrey L; Abrams, Jeffrey; Sledge, George W Jr

Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy

回顾性队列研究分析三阴性乳腺癌的预后,重点关注铂类新辅助治疗的反应

Walsh, Elaine M; Shalaby, Aliaa; O'Loughlin, Mark; Keane, Nessa; Webber, Mark J; Kerin, Michael J; Keane, Maccon M; Glynn, Sharon A; Callagy, Grace M